APA (7th ed.) Citation

Koga, N., Yodogawa, H., Sawada, T., Mushimoto, Y., Nagamitsu, S., Nakamura, K., . . . Inoue, T. (2026). Clinical and Biochemical Improvement After Switching From Agalsidase Alfa to Beta in a Boy With Classic Fabry Disease: A Case Report. Clinical Case Reports, 14(8), 1. https://doi.org/10.1002/ccr3.73353

Chicago Style (17th ed.) Citation

Koga, Nobuhiko, Hiroaki Yodogawa, Takaaki Sawada, Yuichi Mushimoto, Shinichiro Nagamitsu, Kimitoshi Nakamura, Shinichi Hirose, and Takahito Inoue. "Clinical and Biochemical Improvement After Switching From Agalsidase Alfa to Beta in a Boy With Classic Fabry Disease: A Case Report." Clinical Case Reports 14, no. 8 (2026): 1. https://doi.org/10.1002/ccr3.73353.

MLA (9th ed.) Citation

Koga, Nobuhiko, et al. "Clinical and Biochemical Improvement After Switching From Agalsidase Alfa to Beta in a Boy With Classic Fabry Disease: A Case Report." Clinical Case Reports, vol. 14, no. 8, 2026, p. 1, https://doi.org/10.1002/ccr3.73353.